Do not break, crush, or chew them
Wegovy and other GLP-1 receptor agonists have also been linked to an increased risk of acute pancreatitis, gallbladder problems, acute kidney injury, low blood sugar, diabetic retinopathy complications, increased heart rate, and suicidal thoughts
Three major barriers must be overcome to ensure that everyone globally whose health would benefit from GLP-1s can get them: lack of production capacity, availability and affordability
After four weeks on the 2.5 mg dose, your healthcare provider will assess how you are feeling and decide whether to increase your dose
People often look better on the drugs because they have decreased inflammation, Dayan says